13-20414206-TACACACACACAC-TACACAC
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBA1
The NM_015974.3(CRYL1):c.634-825_634-820delGTGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.061 ( 752 hom., cov: 0)
Consequence
CRYL1
NM_015974.3 intron
NM_015974.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.523
Publications
0 publications found
Genes affected
CRYL1 (HGNC:18246): (crystallin lambda 1) The uronate cycle functions as an alternative glucose metabolic pathway, accounting for about 5% of daily glucose catabolism. The product of this gene catalyzes the dehydrogenation of L-gulonate into dehydro-L-gulonate in the uronate cycle. The enzyme requires NAD(H) as a coenzyme, and is inhibited by inorganic phosphate. A similar gene in the rabbit is thought to serve a structural role in the lens of the eye. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 13-20414206-TACACAC-T is Benign according to our data. Variant chr13-20414206-TACACAC-T is described in ClinVar as Benign. ClinVar VariationId is 1181096.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.166 is higher than 0.05.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_015974.3. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CRYL1 | TSL:1 MANE Select | c.634-825_634-820delGTGTGT | intron | N/A | ENSP00000298248.7 | Q9Y2S2-1 | |||
| CRYL1 | TSL:1 | c.568-825_568-820delGTGTGT | intron | N/A | ENSP00000372262.1 | Q9Y2S2-2 | |||
| CRYL1 | c.595-825_595-820delGTGTGT | intron | N/A | ENSP00000557682.1 |
Frequencies
GnomAD3 genomes AF: 0.0604 AC: 9081AN: 150368Hom.: 748 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
9081
AN:
150368
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0605 AC: 9111AN: 150486Hom.: 752 Cov.: 0 AF XY: 0.0613 AC XY: 4501AN XY: 73432 show subpopulations
GnomAD4 genome
AF:
AC:
9111
AN:
150486
Hom.:
Cov.:
0
AF XY:
AC XY:
4501
AN XY:
73432
show subpopulations
African (AFR)
AF:
AC:
6948
AN:
40998
American (AMR)
AF:
AC:
1695
AN:
15126
Ashkenazi Jewish (ASJ)
AF:
AC:
6
AN:
3456
East Asian (EAS)
AF:
AC:
213
AN:
5076
South Asian (SAS)
AF:
AC:
29
AN:
4734
European-Finnish (FIN)
AF:
AC:
22
AN:
10202
Middle Eastern (MID)
AF:
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
AC:
110
AN:
67622
Other (OTH)
AF:
AC:
85
AN:
2074
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
369
738
1108
1477
1846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.